Literature DB >> 27737938

Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque.

Edward B Thorp1.   

Abstract

Entities:  

Keywords:  Editorials; acute coronary syndrome; apolipoprotein; atherosclerosis; cataloging; risk factors

Mesh：

Substances：

Year:  2016        PMID： 27737938      PMCID： PMC5111633          DOI： 10.1161/CIRCRESAHA.116.309794

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  14 in total

Review 1.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 2.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

3.  Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice.

Authors:  Joana R Viola; Patricia Lemnitzer; Yvonne Jansen; Gergely Csaba; Carla Winter; Carlos Neideck; Carlos Silvestre-Roig; Gunnar Dittmar; Yvonne Döring; Maik Drechsler; Christian Weber; Ralf Zimmer; Nicolas Cenac; Oliver Soehnlein
Journal:  Circ Res       Date:  2016-08-16       Impact factor: 17.367

4.  Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy.

Authors:  D A Brezinski; R W Nesto; C N Serhan
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

5.  Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.

Authors:  Gabrielle Fredman; Nazila Kamaly; Stefano Spolitu; Jaclyn Milton; Devram Ghorpade; Raymond Chiasson; George Kuriakose; Mauro Perretti; Omid Farokzhad; Ira Tabas
Journal:  Sci Transl Med       Date:  2015-02-18       Impact factor: 17.956

6.  Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis.

Authors:  Aksam J Merched; Charles N Serhan; Lawrence Chan
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-07

7.  MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.

Authors:  Bishuang Cai; Edward B Thorp; Amanda C Doran; Manikandan Subramanian; Brian E Sansbury; Chyuan-Sheng Lin; Matthew Spite; Gabrielle Fredman; Ira Tabas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-19       Impact factor: 11.205

8.  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis.

Authors:  James H Dwyer; Hooman Allayee; Kathleen M Dwyer; Jing Fan; Huiyun Wu; Rebecca Mar; Aldons J Lusis; Margarete Mehrabian
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245

9.  Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.

Authors:  Aksam J Merched; Kerry Ko; Katherine H Gotlinger; Charles N Serhan; Lawrence Chan
Journal:  FASEB J       Date:  2008-06-17       Impact factor: 5.191

10.  An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.

Authors:  Gabrielle Fredman; Jason Hellmann; Jonathan D Proto; George Kuriakose; Romain A Colas; Bernhard Dorweiler; E Sander Connolly; Robert Solomon; David M Jones; Eric J Heyer; Matthew Spite; Ira Tabas
Journal:  Nat Commun       Date:  2016-09-23       Impact factor: 14.919
View more
  5 in total

Review 1.  Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.

Authors:  Mohan Satish; Devendra K Agrawal
Journal:  Transl Res       Date:  2019-08-12       Impact factor: 7.012

2.  Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease.

Authors:  Luca Liberale; Fabrizio Montecucco; Jean-Claude Tardif; Peter Libby; Giovanni G Camici
Journal:  Eur Heart J       Date:  2020-08-14       Impact factor: 29.983

Review 3.  Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.

Authors:  Mohan Satish; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2019-01-09

Review 4.  Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.

Authors:  Stanislav Kotlyarov; Anna Kotlyarova
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 5.  Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives.

Authors:  Christodoulos Stefanadis; Christos-Konstantinos Antoniou; Dimitrios Tsiachris; Panagiota Pietri
Journal:  J Am Heart Assoc       Date:  2017-03-17       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.